GCI Virtual Summit Thought Leader – Ameet Sule, H&T Presspart
Ameet participated as a thought leader at the GCI Virtual Summit 2020, joining 1000+ registered global leaders in both cannabis and psychedelics.
Check out his bio below:
Ameet Sule is the Director of H&T Presspart’s Inhalation Technology Product Centre (IPTC) which was set up in 2013 at their Blackburn site in a purpose-built laboratory. As well as heading up the IPTC team, Ameet plays a strategic role in the development of current and new innovative products at H&T Presspart.
Ameet has a Master’s Degree in Analytical Chemistry and has worked in the pharmaceutical industry for over 20 years, with his previous experience including the development of drug device combination products (essentially pMDI’s), primary packaging components and analytical test methods as per market needs and regulatory requirements.
At H&T Presspart, in addition to developing new devices, Ameet Sule and his team work closely with customers around the globe to understand and mitigate the front-end development challenges of new and generic products for inhalation drug delivery.
If you are a leader operating in either the cannabis or psychedelics industries, check out the GCI Virtual Summit today! You can submit an application for a complimentary ticket for our 2021 Summit here.
You can also check out exclusive interviews with some of our GCI Virtual Summit thought leaders on the Content Hub.